Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection

Antiviral Research

Volumn 98, Issue 3, 2013, Pages 423-431

  Sasaki, Tadahiro ^a,g   Setthapramote, Chayanee ^b,g   Kurosu, Takeshi ^a,g   Nishimura, Mitsuhiro ^a,g   Asai, Azusa ^a,g   Omokoko, Magot D ^a,g   Pipattanaboon, Chonlatip ^b,g   Pitaksajjakul, Pannamthip ^c,g   Limkittikul, Kriengsak ^c,g   Subchareon, Arunee ^c   Chaichana, Panjaporn ^c   Okabayashi, Tamaki ^c   Hirai, Itaru ^a,d,g   Leaungwutiwong, Pornsawan ^b,g   Misaki, Ryo ^d,g   Fujiyama, Kazuhito ^d,g   Ono, Ken ichiro ^e,g   Okuno, Yoshinobu ^f   Ramasoota, Pongrama ^c,g   Ikuta, Kazuyoshi ^a,g  

^a OSAKA UNIVERSITY   (Japan)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

^d OSAKA UNIVERSITY   (Japan)

^e Medical & Biological Laboratories Co Ltd   (Japan)

^f The Research Foundation for Microbial Diseases of Osaka University   (Japan)

^g Science and Technology Research Partnership for Sustainable Development (SATREPS)   (Japan)

Author keywords

Antibody dependent enhancement; Dengue fever; Dengue hemorrhagic fever; Dengue virus; Human monoclonal antibody; Neutralization

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DEPENDENT ENHANCEMENT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; CELL ASSAY; CLINICAL ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYBRIDOMA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SECONDARY INFECTION; SUCKLING; VIRUS ENVELOPE; VIRUS NEUTRALIZATION;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; ANTIVIRAL AGENTS; COINFECTION; DENGUE; DENGUE VIRUS; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; HYBRIDOMAS; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; SEVERITY OF ILLNESS INDEX; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION; YOUNG ADULT;

DENGUE VIRUS; MUS;

EID: 84877100349     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.03.018     Document Type: Article

References (32)

1. Beltramello M., Williams K.L., Simmons C.P., Macagno A., Simonelli L., Quyen N.T., Sukupolvi-Petty S., Navarro-Sanchez E., Young P.R., de Silva A.M., Rey F.A., Varani L., Whitehead S.S., Diamond M.S., Harris E., Lanzavecchia A., Sallusto F. The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 2010, 8:271-283.
2. Bernardo L., Fleitas O., Pavón A., Hermida L., Guillén G., Guzman M.G. Antibodies induced by dengue virus type 1 and 2 envelope domain III recombinant proteins in monkeys neutralize strains with different genotypes. Clin. Vaccine Immunol. 2009, 16:1829-1831.
3. Costin J.M., Zaitseva E., Kahle K.M., Nicholson C.O., Rowe D.K., Graham A.S., Bazzone L.E., Hogancamp G., Figueroa Sierra M., Fong R.H., Yang S.T., Lin L., Robinson J.E., Doranz B.J., Chernomordik L.V., Michael S.F., Schieffelin J.S., Isern S. Mechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop. J. Virol. 2013, 87:52-66.
4. de Alwis R., Beltramello M., Messer W.B., Sukupolvi-Petty S., Wahala W.M., Kraus A., Olivarez N.P., Pham Q., Brien J.D., Tsai W.Y., Wang W.K., Halstead S., Kliks S., Diamond M.S., Baric R., Lanzavecchia A., Sallusto F., de Silva A.M. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl. Trop. Dis. 2011, 5:e1188.
5. de Alwis R., Smith S.A., Olivarez N.P., Messer W.B., Huynh J.P., Wahala W.M., White L.J., Diamond M.S., Baric R.S., Crowe J.E., de Silva A.M. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl. Acad. Sci. USA 2012, 109:7439-7444.
6. Dejnirattisai W., Jumnainsong A., Onsirisakul N., Fitton P., Vasanawathana S., Limpitikul W., Puttikhunt C., Edwards C., Duangchinda T., Supasa S., Chawansuntati K., Malasit P., Mongkolsapaya J., Screaton G. Cross-reacting antibodies enhance dengue virus infection in humans. Science 2010, 328:745-748.
7. Falconar A.K. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins. Arch. Virol. 1999, 144:2313-2330.
8. García G., Sierra B., Pérez A.B., Aguirre E., Rosado I., Gonzalez N., Izquierdo A., Pupo M., Danay Díaz D.R., Sánchez L., Marcheco B., Hirayama K., Guzmán M.G. Asymptomatic dengue infection in a Cuban population confirms the protective role of the RR variant of the FcγRIIa polymorphism. Am. J. Trop. Med. Hyg. 2010, 82:1153-1156.
9. Gould L.H., Sui J., Foellmer H., Oliphant T., Wang T., Ledizet M., Murakami A., Noonan K., Lambeth C., Kar K., Anderson J.F., de Silva A.M., Diamond M.S., Koski R.A., Marasco W.A., Fikrig E. Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J. Virol. 2005, 79:14606-14613.
10. Guzmán M.G., Kouri G.P., Bravo J., Soler M., Vazquez S., Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 1990, 42:179-184.
11. Halstead S.B., O'Rourke E.J. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 1977, 146:201-217.
12. Kurosu T., Khamlert C., Phanthanawiboon S., Ikuta K., Anantapreecha S. Highly efficient rescue of dengue virus using a co-culture system with mosquito/mammalian cells. Biochem. Biophys. Res. Commun. 2010, 394:398-404.
13. Lai C.Y., Tsai W.Y., Lin S.R., Kao C.L., Hu H.P., King C.C., Wu H.C., Chang G.J., Wang W.K. Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J. Virol. 2008, 82:6631-6643.
14. Midgley C.M., Bajwa-Joseph M., Vasanawathana S., Limpitikul W., Wills B., Flanagan A., Waiyaiya E., Tran H.B., Cowper A.E., Chotiyarnwong P., Grimes J.M., Yoksan S., Malasit P., Simmons C.P., Mongkolsapaya J., Screaton G.R. An in-depth analysis of original antigenic sin in dengue virus infection. J. Virol. 2011, 85:410-421.
15. Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427:313-319.
16. Modis Y., Ogata S., Clements D., Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. J. Virol. 2005, 79:1223-1231.
17. Okuno Y., Igarashi A., Fukai K. Neutralization tests for dengue and Japanese encephalitis viruses by the focus reduction method using peroxidase-anti-peroxidase staining. Biken J. 1978, 21:137-147.
18. Oliphant T., Nybakken G.E., Engle M., Xu Q., Nelson C.A., Sukupolvi-Petty S., Marri A., Lachmi B.E., Olshevsky U., Fremont D.H., Pierson T.C., Diamond M.S. Antibody recognition and neutralization determinants on domains I and II or West Nile virus envelope protein. J. Virol. 2006, 80:12149-12159.
19. Omatsu T., Moi M.L., Hirayama T., Takasaki T., Nakamura S., Tajima S., Ito M., Yoshida T., Saito A., Katakai Y., Akari H., Kurane I. Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J. Gen. Virol. 2011, 92:2272-2280.
20. Rothman A.L. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr. Top. Microbiol. Immunol. 2010, 338:83-98.
21. Sabin A.B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1952, 1:30-50.
22. Sangkawibha N., Rojanasuphot S., Ahandrik S., Viriyapongse S., Jatanasen S., Salitul V., Phanthumachinda B., Halstead S.B. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 1984, 120:653-669.
23. Schieffelin J.S., Costin J.M., Nicholson C.O., Orgeron N.M., Fontaine K.A., Isern S., Michael S.F., Robinson J.E. Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol. J. 2010, 7:28.
24. Setthapramote C., Sasaki T., Puiprom O., Limkittikul K., Pitaksajjakul P., Pipattanaboon C., Sasayama M., Leuangwutiwong P., Phumratanaprapin W., Chamnachanan S., Kusolsuk T., Jittmittraphap A., Asai A., Arias J.F., Hirai I., Kuhara M., Okuno Y., Kurosu T., Ramasoota P., Ikuta K. Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection. Biochem. Biophy. Res. Commun. 2012, 423:867-872.
25. Smith S.A., Zhou Y., Olivarez N.P., Broadwater A.H., de Silva A.M., Crowe J.E. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J. Virol. 2012, 86:2665-2675.
26. Sukupolvi-Petty S., Austin S.K., Engle M., Brien J.D., Dowd K.A., Williams K.L., Johnson S., Rico-Hasse R., Harris E., Pierson T.C., Fremont D.H., Diamond M.S. Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. J. Virol. 2010, 84:9227-9239.
27. Teoh E.P., Kukkaro P., Teo E.W., Lim A.P., Tan T.T., Yip A., Schul W., Aung M., Kostyuchenko V.A., Leo Y.S., Chan S.H., Smith K.G., Chan A.H., Zou G., Ooi E.E., Kemeny D.M., Tan G.K., Ng J.K., Ng M.L., Alonso S., Fisher D., Shi P.Y., Hanson B.J., Lok S.M., MacAry P.A. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci. Transl. Med. 2012, 4:1-9.
28. 2+ influx, leading to apoptosis in avian cells. J. Virol. 2010, 84:3068-3078.
29. van der Schaar H.M., Wilschut J.C., Smit J.M. Role of antibodies in controlling dengue virus infection. Immunobiology 2009, 214:613-629.
30. Yasugi M., Kubota-Koketsu R., Yamashita A., Kawashita N., Du A., Misaki R., Kuhara M., Boonsathorn N., Fujiyama K., Okuno Y., Nakaya T., Ikuta K. Human monoclonal antibodies broadly protective against influenza B virus. PLoS Pathog. 2013, 9:e1003150.
31. Zompi S., Harris E. Animal models of dengue virus infection. Viruses 2012, 4:62-82.
32. Zou G., Kukkaro P., Lok S.M., Ng J.K., Tan G.K., Hanson B.J., Alonso S., MacAry P.A., Shi P.Y. Resistance analysis of an antibody that selectively inhibits dengue virus serotype-1. Antiviral Res. 2012, 95:216-223.